Medical Devices Into the Philippines: FDA A/B/C/D Classes and the CMDN/CMDR Process

It All Starts With Classification: Four Risk Classes A/B/C/D

Philippine medical-device regulation is built on the ASEAN Medical Device Directive (AMDD), sorting devices into four risk classes:

• Class A: low risk (e.g. surgical gloves, bandages, some basic consumables).
• Class B: low-moderate risk (e.g. hypodermic needles, some blood-pressure devices).
• Class C: moderate-high risk (e.g. some implants, more complex equipment).
• Class D: high risk (e.g. cardiac implants, some life-sustaining devices).

The higher the class, the heavier the documents, assessment and timeline. Classification is the starting point for everything — misclassify and the track, documents and timeline are all wrong, with a costly redo. Note that which class a given product falls into, and which devices are pulled into mandatory registration, keep being adjusted by FDA circulars — the regulated scope has broadly expanded in recent years, so always follow the latest rules and case-by-case determination. For the two-step FDA framework overall, see our full FDA product registration guide.

CMDN Notification vs CMDR Registration: Two Tracks

Once the class is set, it maps to one of two product-level tracks:

• CMDN (Notification): usually for low-risk Class A devices, a relatively light process yielding a device notification certificate.
• CMDR (Registration): for higher-risk Classes B, C and D, requiring a full technical dossier and assessment — a notably higher bar and longer timeline, yielding a device registration certificate.

Watch this carefully: the boundary between CMDN and CMDR is not fixed. Historically many devices needed only a simpler notification or listing, but the FDA has been progressively pulling more categories into the registration (CMDR) requirement, with transitional arrangements. So "it used to be just a notification" doesn't mean it still is — confirm which track your product takes under the currently effective FDA circulars. When the boundary is unclear, have a consultant fix the classification early.

The LTO and Agent: Who Is the "Licensed Party"

As with other FDA categories, before the product level you first need a company-level License to Operate (LTO) — a medical-device establishment license (importer/distributor/manufacturer). Without an LTO, the product's CMDN/CMDR cannot be submitted.

Foreign device makers usually have two paths:

• Set up a Philippine entity and obtain your own device LTO: for makers who want full control of the registration and are in for the long term.
• Appoint a licensed local agent/importer: a local authorized representative that already holds a device LTO acts as the registration/licensed party, so the overseas maker enters compliantly without first incorporating, and registration can run in parallel with company setup.

The agent route shortens entry time, but the registration party is the agent, so transferring it into your own name later needs terms agreed up front. Who serves as authorized representative also determines where post-market duties like adverse-event reporting and recalls land — so choose an agent for credentials and compliance capability, not price alone.

Document Checklist: The CSDT Dossier Is the Core

Device registration (especially Classes B/C/D) is document-heavy; the core usually includes:

• Entity and license: the device LTO, incorporation documents, authorized-representative details.
• CSDT technical dossier: the ASEAN Common Submission Dossier Template, covering device description, intended use, design and manufacturing information, performance and safety verification, risk management, labeling and instructions — the heart of the assessment.
• Quality system: the manufacturer's ISO 13485 or equivalent quality-management-system evidence.
• Free-sale proof: a Certificate of Free Sale (CFS) or Certificate to Foreign Government (CFG) from the country of origin, showing the device may be legally sold there.
• Authorization and labeling: the overseas manufacturer's letter of authorization and compliant labels and instructions for use.
• Legalization: foreign documents usually need notarization plus authentication or Apostille to be accepted.

The higher the class, the more detailed the CSDT and verification data. Translation, notarization and authentication of foreign documents are often the most time-consuming steps, so starting early saves weeks. The full document package can be coordinated by the Yixing product-access team.

Timeline and Cost: Higher Class, Longer Wait

Timeline: device approval times widen sharply with risk class — a Class A CMDN is usually faster, Classes B/C/D CMDR noticeably longer, and high-risk Class D the heaviest. Actual timing also depends on document completeness and resubmissions — subject to current FDA processing, so no exact day count can be promised.

Cost: official fees (by class, validity and product) plus agent service fees; the higher the class, the higher the fees typically run, varying with product and agent. We list no precise figures here — follow current FDA fees and agent quotes.

A practical note: what slows things is usually not the assessment itself but an incomplete CSDT and back-and-forth over foreign-document legalization and missing items. Mapping the timeline for the LTO, classification, CSDT and legalized documents up front is the key to shortening time-to-shelf. Customs entry is a separate stage — see our guide to Philippine customs clearance.

Post-Market Oversight: Registration Isn't the End

Getting the CMDN/CMDR is only the start; medical-device post-market surveillance is stricter than for ordinary products and must be sustained:

• Adverse-event reporting: serious device-related adverse events and malfunctions generally must be reported to the FDA within set timeframes.
• Recall and correction: on discovering safety or quality issues, you must cooperate with recalls and field corrective actions and keep records.
• Changes and renewal: a registration/notification has a validity period needing renewal; major changes to design, labeling or manufacturer usually require re-filing.
• Sampling and advertising: the FDA samples marketed devices; device advertising and promotion are also regulated and may not exaggerate or make unapproved claims.

Treat compliance as an ongoing obligation across the product life cycle, not a one-off certificate. The authorized representative carries considerable responsibility here — another reason to pick a reliable agent.

Summary and Disclaimer

The main line for devices into the Philippines is clear: set the risk class (A/B/C/D) → confirm CMDN or CMDR → obtain a device LTO (or appoint a licensed agent) → assemble and legalize the CSDT, ISO 13485 and CFS → register and obtain the certificate → sustain post-market surveillance. The usual failure points are classification and the CSDT/legalized documents.

This article is general information only and is not legal, regulatory or medical advice. The Philippine FDA's device classification, CMDN/CMDR scope, documents, timelines, fees and post-market requirements keep updating via circulars and are highly case-specific; everything is governed by the current FDA rules and professional advice for your product. Bring your product description, classification view and quality documents, and start with a free classification and market-entry assessment from Yixing — so you don't misclassify and lose months.